Citation tools
"Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant 225Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study." Journal of Nuclear Medicine
(2022):
jnumed.122.264043.
Web. 25 April. 2024.